Evaluation of Rostrum’s VQm® by Southlake Regional Health Centre Demonstrated Potential Cost-Savings Strategies to Manage Mechanically Ventilated Patients in the ICU
Over 350,000 patients in Canada are admitted into the intensive care unit (ICU) annually, with 40% of those patients needing invasive mechanical ventilation. Managing mechanically ventilated patients can be complex due to providers having to simultaneously treat the underlying condition and the potential impacts a ventilator may have on the patient, which can lead to costly complications.
Rostrum Medical announces and is excited to share the publication of initial validation results of its novel VQm® System.
Rostrum Medical, which has developed and designed the VQm® System to address these challenges in patient management and is excited to announce the publication of its initial clinical validation in a porcine model.
Rostrum Medical Welcomes New Advisor to Support its’ Global Commercialization Plan and Strategy
Rostrum Medical® announces and welcomes Mr. Samuel Cochrane, an experienced financial executive, as an advisor.
Rostrum Medical Innovation Partners with Toronto General Hospital for Upcoming Evaluation of its’ VQm® System
Rostrum Medical today announced its partnership with Toronto General Hospital to begin an evaluation for its innovative device, the VQm® System.
Rostrum Medical Innovations Presents Results of VQm® System’s Clinical Validation at the American Society of Anesthesiologists
Rostrum Medical Innovations is pleased to announce the results from its ongoing clinical validations were presented at this year’s American Society of Anesthesiologists congress in New Orleans.
Rostrum Medical Welcomes Ms. Golddy Kaur to Rostrum’s Board of Directors
Rostrum is pleased to announce the appointment of Ms. Golddy Kaur to Rostrum Medical’s board of directors. She joins Scott Philipps, Daguang Wang, Dr Georg Brady and Awni Ayoubi to expand the company’s strategic capabilities and solidify our path to commercialisation of The VQm® System.
Rostrum Medical Innovation Receives Health Canada Clearance for its 2nd Generation VQm Pulmonary Health Monitor™
Rostrum Medical is pleased to announce Health Canada Licensing approval for its 2nd generation VQm®. The VQm® System model SØ6 will feature its usability experience to support the clinical workflow in the intensive care unit.
New Study Confirms Agreement of Pulmonary Blood Flow Measurements between VQm PHM™ and Current Clinical Gold Standard.
A study recently conducted on mechanically ventilated patients, undergoing cardiopulmonary bypass (CPB) to evaluate measurements of Pulmonary Blood Flow (PBF) acquired from the non-invasive, bedside VQm Pulmonary Health Monitor™ (PHM) confirms correlation with current clinical gold standard.
Rostrum Medical to Present New Data at the European Society of Intensive Care Medicine
Rostrum Medical has been selected to present in the congress for the second consecutive year. This year, Dr. (Prof) Neal Fleming, will be presenting an abstract entitled “Non-invasive Monitoring of Pulmonary Blood Flow in Mechanically Ventilated Adults”.
Rostrum Medical® Announces Expansion of Senior Leadership Team to Accelerate Growth
We are pleased to welcome Kipton Lade to the senior leadership team at Rostrum Medical Innovations. Mr. Lade has been appointed to the position of Vice President – Global Sales & Marketing to lead its Rostrum’s business development and global marketing efforts.
Rostrum Medical® to attend the Canadian Lunar Workshop 2021
Rostrum Medical will attend the first Canadian Lunar Workshop organized by The Canadian Space Agency (CSA). The virtual workshop will commence on June 14th and run through June 16th, 2021.
Rostrum Welcomes Starfish Medical Founder and CEO Scott Phillips
Rostrum Medical Innovations, a medical device company focused on the development of useful links between medicine and engineering, today announced the appointment of Scott Phillips to its Board of Directors, effective April 1, 2021.
Rostrum Medical® commences first human clinical trial
Rostrum is pleased to announce its successful transition into human clinical trials. The first subjects were successfully enrolled using the Rostrum VQm Pulmonary Health Monitor at UC Davis (California) last week.
Rostrum Medical® to attend ESICM Lives 2020
Rostrum Medical will attend the 33rd annual European Society of Intensive Care Medicine (“ESICM”) LIVES Digital congress. The ESICM has an outstanding program while connecting a multidisciplinary network of physicians, researchers, nurses, and allied health professionals across the globe.
Rostrum’s Efforts to address COVID-19 challenges
As the world is facing unprecedented changes and challenges, Rostrum supports all affected individuals during this challenging time.
Rostrum & Thornhill research announce technology development agreement.
Thornhill and Rostrum celebrate the finalization of a Technology Development Agreement which includes the licensing of certain Thornhill IP and an investment by Rostrum into Thornhill.